Holen Sie sich die Stockscreener-App
2.10
1.45%
0.03
Finanzdaten der Aclaris Therapeutics Inc-Aktie (ACRS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
22.13%
1.777
|
1.455 | 9.211 | 4.346 | - |
| Cost Of Revenue |
1.78%
0.515
|
0.506 | 0.705 | 0.654 | - |
| Gross Profit |
32.98%
1.262
|
0.949 | 8.506 | 3.692 | - |
Operating Expenses
|
3.35%
19.67
|
19.03 | 108.18 | 14.16 | - |
| Benefits Costs and Expenses |
4.03%
17.21
|
16.54 | 105.76 | 14.82 | - |
| Costs And Expenses |
3.31%
20.18
|
19.54 | 108.89 | 14.82 | - |
| Operating Income/Loss |
1.79%
-18.41
|
-18.08 | -99.67 | -10.47 | - |
| Nonoperating Income/Loss |
0.67%
2.979
|
2.999 | 3.123 | 2.885 | - |
| Income/Loss From Continuing Operations Before Tax |
2.28%
-15.43
|
-15.09 | -96.55 | -10.47 | -10.99 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
2.28%
-15.43
|
-15.09 | -96.55 | -7.586 | -10.99 |
|
Net Income/Loss
|
2.28%
-15.43
|
-15.09 | -96.55 | -7.586 | -10.99 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.16%
122.58
|
122.39 | 6.0469 | 71.38 | - |
| Diluted Average Shares |
0.16%
122.58
|
122.39 | 6.0469 | 71.38 | - |
| Basic Earnings Per Share |
8.33%
-0.13
|
-0.12 | -1.21 | -0.11 | - |
| Diluted Earnings Per Share |
8.33%
-0.13
|
-0.12 | -1.21 | -0.11 | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):